ResearchSpace

Patents, ethics, biosafety and regulation using CRISPR technology

Show simple item record

dc.contributor.author Nxumalo, Precious Z
dc.contributor.author Takundwa, MM
dc.contributor.author Thimiri Govinda Raj, Deepak B
dc.date.accessioned 2021-10-09T08:58:44Z
dc.date.available 2021-10-09T08:58:44Z
dc.date.issued 2021-02
dc.identifier.citation Nxumalo, P.Z., Takundwa, M. & Thimiri Govinda Raj, D.B. 2021. Patents, ethics, biosafety and regulation using CRISPR technology. <i>Molecular Biology and Translational Science, 181.</i> http://hdl.handle.net/10204/12127 en_ZA
dc.identifier.issn 1877-1173
dc.identifier.uri https://doi.org/10.1016/bs.pmbts.2021.01.023
dc.identifier.uri http://hdl.handle.net/10204/12127
dc.description.abstract In this review chapter, we provide full comprehensive analysis on the patent, ethics and biosafety regulation with respect to the application of CRISPR technology in mammalian systems. We focused on recent development in CRISPR technology and its patent landscape between countries such as US, European Union, China and Australia. Further, we emphasized on the current scenarios on the ethics regulations with respect to CRISPR research, its applicability in patent and technology transfer. Finally, we elaborated on the biosafety regulation on CRISPR/Cas9 technology application in both mammalian and non-mammalian host system. en_US
dc.format Abstract en_US
dc.language.iso en en_US
dc.relation.uri https://doi.org/10.1016/bs.pmbts.2021.01.023 en_US
dc.relation.uri https://www.sciencedirect.com/science/article/abs/pii/S187711732100034X en_US
dc.source Molecular Biology and Translational Science, 181 en_US
dc.subject Ethics and biosafety regulation en_US
dc.subject CRISPR technology en_US
dc.title Patents, ethics, biosafety and regulation using CRISPR technology en_US
dc.type Article en_US
dc.description.pages 345-365 en_US
dc.description.note Copyright: 2021 Elsevier Inc. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, please consult the publisher's website: https://www.sciencedirect.com/science/article/abs/pii/S187711732100034X en_US
dc.description.cluster Next Generation Health en_US
dc.description.impactarea Synthetic Nanobiotech&Biomachi en_US
dc.identifier.apacitation Nxumalo, P. Z., Takundwa, M., & Thimiri Govinda Raj, D. B. (2021). Patents, ethics, biosafety and regulation using CRISPR technology. <i>Molecular Biology and Translational Science, 181</i>, http://hdl.handle.net/10204/12127 en_ZA
dc.identifier.chicagocitation Nxumalo, Precious Z, MM Takundwa, and Deepak B Thimiri Govinda Raj "Patents, ethics, biosafety and regulation using CRISPR technology." <i>Molecular Biology and Translational Science, 181</i> (2021) http://hdl.handle.net/10204/12127 en_ZA
dc.identifier.vancouvercitation Nxumalo PZ, Takundwa M, Thimiri Govinda Raj DB. Patents, ethics, biosafety and regulation using CRISPR technology. Molecular Biology and Translational Science, 181. 2021; http://hdl.handle.net/10204/12127. en_ZA
dc.identifier.ris TY - Article AU - Nxumalo, Precious Z AU - Takundwa, MM AU - Thimiri Govinda Raj, Deepak B AB - In this review chapter, we provide full comprehensive analysis on the patent, ethics and biosafety regulation with respect to the application of CRISPR technology in mammalian systems. We focused on recent development in CRISPR technology and its patent landscape between countries such as US, European Union, China and Australia. Further, we emphasized on the current scenarios on the ethics regulations with respect to CRISPR research, its applicability in patent and technology transfer. Finally, we elaborated on the biosafety regulation on CRISPR/Cas9 technology application in both mammalian and non-mammalian host system. DA - 2021-02 DB - ResearchSpace DP - CSIR J1 - Molecular Biology and Translational Science, 181 KW - Ethics and biosafety regulation KW - CRISPR technology LK - https://researchspace.csir.co.za PY - 2021 SM - 1877-1173 T1 - Patents, ethics, biosafety and regulation using CRISPR technology TI - Patents, ethics, biosafety and regulation using CRISPR technology UR - http://hdl.handle.net/10204/12127 ER - en_ZA
dc.identifier.worklist 24995 en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record